 Taken together, these advantages have made it the preferred vaccine of many countries, and it has long been preferred by the global eradication initiative.The primary disadvantage of the OPV derives from its inherent nature as an attenuated but active virus.It can induce vaccine-associated paralytic poliomyelitis (VAPP) in approximately one individual per every 2.4million doses administered.